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Abstract 
Pleural effusion directly attributable to mul-
tiple myeloma is exceedingly uncommon and is
said to occur in only 1-2% of cases. Of these
around 80% occur in IgA disease. We report a
case of myelomatous pleural effusion (proven
on cytological and immunohistochemical analy-
sis) in a patient with the IgG-ʺ subtype. We
describe the diagnosis, pathogenesis and man-
agement of this condition and show the radio-
logical and cytological evidence of the case.
Introduction
Multiple myeloma is a clonal B-cell malig-
nancy characterized by proliferation of plasma
cells accumulating mainly in the bone marrow
and secreting paraprotein.
1 Myeloma accounts
for  around  1%  of  all  malignancies  and  UK
national statistics for 2006 report an incidence
of 6.4 cases per 100,000 annually.
2 Mean age at
diagnosis is 65 years.
Pleural  effusion  directly  attributable  to
myeloma is exceedingly rare (1-2% of cases).
3
We present a case of pleural effusion arising
rapidly in a patient with long-standing multiple
myeloma and found to be a myelomatous effu-
sion.
Case Report
A  74-year  old  man  with  longstanding  IgG
kappa myeloma presented with a two week his-
tory of increasing dyspnoea on exertion. Blood
tests  showed  a  normocytic  anemia  (Hb:  7.4
g/dL,  MCV:  90.1  fl),  and  renal  impairment
(urea:  9.2  mmol/L,  creatinine:  248  µmol/L).
Serum  electrophoresis  suggested  rapid  dis-
ease progression with an increase in parapro-
tein from 14 g/L to 50 g/L over a six week peri-
od. Chest radiographs showed a large left sided
pleural effusion (Figure 1).  Diagnostic tap of
the  effusion  produced  heavily  blood  stained
fluid with features suggestive of an exudate
(pH: 7.62, total protein: 93 g/L, LDH: 506 U/L).
The  effusion  persisted,  necessitating  thera-
peutic drainage which produced four liters of
bloodstained  fluid.  Computed  tomography
(CT) of the chest was radiologically suggestive
of  mesothelioma  (Figure  2)  but  cytological
analysis  of  the  pleural  fluid  showed  plasma
cells consistent with myeloma (Figure 3).  
Subsequent  immunohistochemistry
revealed  ʺ light  chain  restriction  and  VS38
positivity. A diagnosis of pleural effusion sec-
ondary to multiple myeloma was made and the
patient  was  commenced  on  bortezomib  and
dexamethasone therapy seven days after first
presenting. No further pleural aspiration was
necessary  from  this  point  and  repeat  chest
radiography (Figure 4) taken seven days after
starting  treatment  showed  resolving  pleural
disease  and  the  patient  reported  improved
symptomatology.
Discussion
Pleural effusion is uncommon in multiple
myeloma; it has been suggested that it occurs
in approximately 6% of cases. Most of these
are not directly due to myelomatous infiltra-
tion  but  to  related  pathologies  such  as  pul-
monary embolus, heart failure and nephrotic
syndrome. Effusion directly due to myeloma is
said to occur in less than 1% of cases with
approximately 80% of these being in IgA dis-
ease.
3
Involvement of the cavities is an ominous
feature in multiple myeloma and thought to
represent  either  a  late  manifestation  in  the
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Figure 1. Chest radiographs showed a large
left sided pleural effusion. 
Figure  2.  Computed  tomography  of  the
chest  was  radiologically  suggestive  of
mesothelioma.
Figure 4. Repeat chest radiography taken
seven days after starting treatment showed
resolving pleural disease.
Figure 3. Cytological analysis of the pleural
fluid showed plasma cells consistent with
myeloma.[page 98] [Hematology Reviews 2009; 1:e18]
natural history of the disease or a feature of
the  aggressive  behavior  of  myeloma.
Diagnosis is based on cytological analysis and
immunohistochemical staining, pleural biopsy
may  also  yield  a  diagnosis  of  myeloma.
Malignant plasma cells within the cytological
preparation  show  a  typical  basophilic  cyto-
plasm with large, eccentric nuclei and promi-
nent nucleoli.
4
Several possible mechanisms are postulat-
ed for myelomatous pleural effusion: invasion
from adjacent skeletal lesions; extension from
chest wall plasmacytomas; tumor infiltration
of  the  pleura;  and  mediastinal  lymph  node
involvement causing lymphatic obstruction.
4,5
Currently, the exact mechanism of pathogene-
sis remains unknown.
The  management  is  two-stage.  First,  the
effects of the effusion must be alleviated with 
therapeutic  and  diagnostic  thoracocentesis.
Once  myelomatous  pleural  effusion  is  con-
firmed on cytology, and/or immunohistochem-
istry,  systemic  chemotherapy  is  required  to
slow the advance of the disease. There is as
yet no consensus as to how best to manage
this rapid and aggressive phase of disease but
we  anecdotally  show  evidence  of  a  good
response  to  bortezomib  and  dexamethasone
therapy.
We  suggest  that  this  case  highlights  the
vital importance of diagnostic clarity, where
possible, in finding the underlying etiology of
a pleural effusion.  Myelomatous pleural effu-
sion carries a poorer prognosis and more work
is needed to understand the exact pathogene-
sis of this condition.
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